Notice Number: NOT-FD-16-005
Release Date: March 3, 2016
Estimated Publication Date of Announcement: March 2016
First Estimated Application Due Date: May 2016
Earliest Estimated Award Date: September 2016
Earliest Estimated Start Date: September 2016
U.S. Food and Drug Administration (FDA)
The U.S. Food and Drug Administration, Office of Regulatory Affairs, intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications for cooperative agreements to advance efforts to improve and develop state drug residue prevention programs. The FDA intends to provide assistance to promote the prevention of illegal drug residues in animal derived foods and to protect consumer exposure to drug residues in the edible products of food animals.
The proposed objective of FDA’s ORA cooperative agreement program is to develop, complement and enhance state drug residue prevention programs through educational outreach and training activities. Related activities may include and are not limited to the following:
This proposed opportunity may potentially be available to state government agencies that have current FDA tissue residue inspection contracts or have previously been awarded an FDA tissue residue inspection contract.
This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
The FOA is expected to be published in March 2016 with an expected application due date in May 2016.
APPLICATIONS ARE NOT BEING SOLICITED AT THIS TIME.
Please direct all inquiries to:
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.